Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

tACS for Neuropathic Pain Management After SCI

NCT: NCT06029075 · RECRUITING

NCT IDNCT06029075
StatusRECRUITING
Start Date2025-09-01
Completion2028-03-31
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for neuropathic pain management in people after spinal cord injury.

Frequently Asked Questions

What is tACS for Neuropathic Pain Management After SCI?

tACS for Neuropathic Pain Management After SCI is a clinical trial registered under NCT06029075. Current status: RECRUITING.

What is the status of NCT06029075?

The current status of NCT06029075 (tACS for Neuropathic Pain Management After SCI) is: RECRUITING.

When did tACS for Neuropathic Pain Management After SCI start?

tACS for Neuropathic Pain Management After SCI started on 2025-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.